Despite Endo International plc – Ordinary Shares (NASDAQ:ENDP) delivering a second-quarter earnings beat on Tuesday, with the management team forced to pull back …
Valeant Still Has Higher Risk Profile Despite ‘Solid’ Q2 Results Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares crashed 10% yesterday after the troubled biotech …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that it has reached agreements to resolve virtually all known U.S.
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced it has entered into a definitive agreement to sell Mexico City based Grupo Farmacéutico SOMAR to Advent International for approximately $124 million subject …
Cantor analyst Louise Chen is out with initiation reports assessing Valeant Pharmaceuticals Intl Inc (NYSE:VRX) with more confidence than the rest of the Street’s …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and Endo International plc – Ordinary Shares (NASDAQ:ENDP) each beat expectations on Tuesday as …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) reported first-quarter 2017 financial results, including: Revenues of $1,038 million, an 8 percent increase compared to …
Endo International plc (NASDAQ:ENDP) is on investors’ radars after the FDA’s Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug …
William Blair analyst Tim Lugo is quite apprehensive on Endo International plc – Ordinary Shares (NASDAQ:ENDP) on the heels of yesterday morning’s review materials …
Top analyst Irina Rivkind Koffler at Mizuho is all the more bullish on Endo International plc – Ordinary Shares (NASDAQ:ENDP) following the subdued …